亚洲最大福利网站_4hu四虎永久网址_麻豆国产原创_国产成人av一区二区

FDA approves new DNA-based test to determine blood compatibility
date:Oct 12, 2018
The U.S. Food and Drug Administration today approved ID CORE XT, a molecular-based assay used in blood transfusion medicine to help determine blood compatibility. The assay can be used to determine blood donor and patient non-ABO red blood cell (RBC) types. ID CORE XT is the second molecular assay approved for use in transfusion medicine, and the first to report genotypes as final results.
The approval of the ID CORE XT Test can streamline blood compatibility testing and provides an additional a

12/21 23:23